Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2023 6.25%
December 31, 2022 10.75%
September 30, 2022 16.32%
June 30, 2022 13.92%
March 31, 2022 8.48%
December 31, 2021 5.10%
September 30, 2021 5.33%
June 30, 2021 8.12%
March 31, 2021 16.13%
December 31, 2020 14.81%
September 30, 2020 23.03%
June 30, 2020 15.59%
March 31, 2020 14.10%
December 31, 2019 2.23%
September 30, 2019 11.95%
June 30, 2019 10.43%
March 31, 2019 13.95%
December 31, 2018 -0.50%
September 30, 2018 14.70%
June 30, 2018 16.50%
March 31, 2018 14.29%
December 31, 2017 12.45%
September 30, 2017 14.10%
June 30, 2017 7.08%
March 31, 2017 14.02%
Date Value
December 31, 2016 9.52%
September 30, 2016 17.20%
June 30, 2016 18.42%
March 31, 2016 13.75%
December 31, 2015 12.98%
September 30, 2015 13.73%
June 30, 2015 18.24%
March 31, 2015 13.59%
December 31, 2014 17.97%
September 30, 2014 19.20%
June 30, 2014 18.13%
March 31, 2014 21.75%
December 31, 2013 15.98%
September 30, 2013 3.65%
June 30, 2013 4.06%
March 31, 2013 16.87%
December 31, 2012 0.41%
September 30, 2012 15.03%
June 30, 2012 5.52%
March 31, 2012 17.61%
December 31, 2011 16.56%
September 30, 2011 19.64%
June 30, 2011 17.02%
March 31, 2011 22.29%
December 31, 2010 20.97%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Accuray, Inc. 34.76%
IDEXX Laboratories, Inc. 64.07%
Neogen Corp. 37.59%
Orthofix Medical, Inc. 69.55%
QuidelOrtho Corp. 35.75%